Charles Gregoire de Rothschild to Advise Exmovere

        Print
| Source: Exmovere Holdings, Inc.

MCLEAN, Va., Dec. 12, 2011 (GLOBE NEWSWIRE) -- Gregoire de Rothschild has agreed to advise Exmovere Holdings, Inc (Frankfurt:X3M). Mr. de Rothschild and his company GDR Privee, Inc. today expressed full support for the company, its products and its mission. Mr. de Rothschild stated, "Exmovere's biosensor and emotion detection technologies are revolutionary and have the potential to help millions of first time mothers, chronically ill persons and amputees, disabled veterans and others with mobility challenges around the world."   He added, "David Bychkov is a serious, honest and capable CEO.  After observing his leadership style in action, I am convinced that Exmovere Holdings is worthy of GDR Privee's attention." 

One of Exmovere's signature products is Exmobaby – a patented, biosensor "smart garment" for infants. The technology tracks vital signs and sends alerts to a parent's cell phone, if needed. Exmobaby will be launched for US consumers next year in partnership with AT&T and Mr. de Rothschild noted that, "there is huge potential for the new product worldwide." David Bychkov stated, "Exmobaby, supported by AT&T and other key worldwide players in healthcare and wireless technologies, has the potential to significantly address the fear of SIDS by first-time moms, about 4 million in the U.S. alone." For more information, see the Exmobaby website at http://exmobaby.exmovere.com.

GDR Privee, Inc. is known for its key contacts and ability to cement significant strategic alliances. The commitment by GDR Privee comes at a pivotal time for Exmovere Holdings, Inc. as it prepares to launch most of its new products in 2012. 

About Exmovere Holdings Inc.

Exmovere Holdings, Inc. is focused on government and consumer applications for healthcare, mobility, and security and the practical applications of the study of human emotion. The Chariot, Exmobaby pajamas, and the Telepath wristwatch are instrumental in the build out of this vision as a solid representation of Exmovere's push into enhancing human mobility, infant safety, and telemedicine. The company plans on continuing along a path of solid and emotional driven design with a product offering that changes the way people look at the world. 

In addition to Exmobaby, the company's other products include revolutionary and leading edge technologies designed to address the needs of large, targeted markets around the world. Its Telepath wristwatch for senior citizens and chronically ill patients provides constant monitoring and wireless alerts. The Kenji smartphone app serves the world's first mental fitness guide and de-stress coach to any iPhone user. The Chariot uses many of the same technologies and vital sign monitors to deliver healthier mobility to the disabled and wounded veterans. Some of the same technologies are also being built into automobile and truck components for the safety of drivers. All of these products are aimed at significant populations numbering in the millions. For more detail, see the company's website at http://www.exmovere.com.

The company believes these products will continue to be on the cutting edge and establish paradigm shifts in the markets we serve.  Further inquiries into any of our exciting and innovative product offerings or our plans for go-to-market introductions during 2012 should be directed to the contact person listed below.

The Exmovere Holdings, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7861

Exmovere Holdings, Inc.
Dale Allman, Special Advisor for Investor Relations
Tel: + 1-703-663-4090
Fax: +1-703 663 7350
Email: 
http://www.exmovere.com